The Brod Group

The Brod Group is a specialized consulting firm focused on Clinical Outcomes Assessment (COA) and Patient-Reported Outcomes (PRO) strategy within the life sciences industry. The company provides expert guidance on the development, validation, and implementation of patient-centric endpoints for clinical trials and regulatory submissions to the FDA and EMA. Their services include qualitative research, instrument design, and strategic advice to ensure that the patient voice is effectively captured and utilized in drug development. By bridging the gap between clinical research and patient experience, The Brod Group helps pharmaceutical and biotech companies demonstrate the value and impact of their therapies. The firm is led by Dorothy Brod and is recognized for its deep expertise in navigating the complex regulatory landscape surrounding patient-reported data.